De Quervain's Tenosynovitis: Diagnosis & Ultrasound-Guided Injection

De Quervain's tenosynovitis is a common, painful irritation of the tendons on the thumb side of the wrist. It typically hurts when you grip, lift, wring or twist, and it's especially common around pregnancy and in the early months of lifting and carrying a baby, as well as in anyone doing repetitive thumb and wrist movements. The good news is that it responds well to treatment. The best evidence supports a corticosteroid injection, usually combined with a short spell in a thumb-spica splint, and when an injection is used, ultrasound lets me see the tendons, confirm the medication reaches the right compartment and steer clear of the nearby nerve.

What is De Quervain's tenosynovitis?

De Quervain's affects the first dorsal compartment at the thumb side of the wrist, a small tunnel carrying two tendons, the abductor pollicis longus (APL) and extensor pollicis brevis (EPB), which move the thumb. In De Quervain's, the sheath around these tendons becomes thickened and irritated, so they no longer glide smoothly, causing pain, swelling and sometimes catching. It's often linked to repetitive gripping, lifting and twisting, and is common around pregnancy and in the early months of caring for a baby. One anatomical detail matters for treatment: in many people a small septum divides the compartment, giving the EPB tendon its own separate subcompartment, which can change how an injection needs to be placed.

Symptoms and diagnosis

Typical symptoms include:

• pain and tenderness over the thumb side of the wrist;
• pain with gripping, pinching, lifting or twisting;
• swelling near the base of the thumb;
• sometimes catching or a creaking sensation as the tendons move.

The diagnosis is usually clinical. A well-known test is Finkelstein's manoeuvre, tucking the thumb into the palm and gently bending the wrist towards the little finger, which reproduces the pain. It's also important to check the pain isn't actually coming from the thumb-base (CMC) joint, which can cause similar symptoms but needs different treatment. Ultrasound helps confirm the diagnosis and exclude these mimics.

What ultrasound shows

With a high-frequency probe, ultrasound gives a clear view of the first dorsal compartment. It can show:

• thickening of the tendon sheath and surrounding fluid;
• increased blood flow on Doppler when the area is actively inflamed;
• whether a septum separates the EPB into its own subcompartment;
• the exact position of the tendons;
• nearby structures such as the superficial radial nerve.

This is genuinely useful information. Identifying a septum matters, because a separate EPB subcompartment is a recognised reason a blind injection can miss and fail. Seeing the tendons and the nerve also helps avoid injecting into the tendon itself or too close to the nerve.

Treatment: splint and injection

For most people, the best-supported approach combines a corticosteroid injection with a short spell in a thumb-spica splint. The evidence here is strong. A 2024 systematic review and meta-analysis of 16 randomised studies (1,206 patients) found corticosteroid injection more successful than immobilisation alone, and injection combined with immobilisation more effective than either on its own. This confirmed a 2023 JAMA Network Open network meta-analysis of 30 trials (1,663 patients), which recommended a corticosteroid injection followed by roughly three to four weeks in a thumb-spica splint.

So the splint isn't an afterthought, adding roughly three to four weeks of thumb-spica immobilisation after the injection gives better functional results than injection alone. Modifying the activities that aggravate it, the repetitive gripping and twisting, also helps.

Evidence: good, injection plus a thumb-spica splint is the best-supported first-line treatment

Does ultrasound guidance make the injection better?

Here I'll be straight with you, because the honest answer is nuanced. Ultrasound clearly improves what the clinician can see and how accurately the medication is placed. What it hasn't clearly done, yet, is prove a large advantage in patient outcomes over a well-performed landmark injection in properly designed trials.

Two small but credible randomised trials, one in 2020 and one in 2024, found no statistically significant difference between ultrasound-guided and blind or palpation-guided injection in pain, function, satisfaction or complications, though both hinted at slightly less recurrence and fewer skin side-effects with ultrasound. Reviews that favour ultrasound tend to rest on small samples, mixed study types or very-low-certainty evidence. One frequently cited 2018 trial that reported fewer skin complications with ultrasound has since been retracted, so it shouldn't be relied on.

So where does that leave ultrasound? In my view it's most valuable when it counts: after a first injection has failed, when the anatomy is variable, or when a septum means the EPB needs to be targeted specifically. A 2022 randomised trial in people with a complete septum found that accurately injecting the EPB subcompartment alone worked as well as injecting both, with less skin hypopigmentation, in other words, precise targeting can matter. I use ultrasound routinely because it confirms the medication reaches the right compartment and helps me avoid the tendon and the nearby nerve, but I won't oversell it: for a straightforward first injection, a well-placed landmark injection is also an evidence-supported option.

Evidence: ultrasound improves accuracy; clinical superiority over landmark injection is not yet proven

Is it safe?

Corticosteroid injection is generally safe. The recognised side-effects are usually minor and include temporary pain after the injection, a pale patch of skin (hypopigmentation), thinning of the fat under the skin, and short-lived changes in sensation. More serious problems, infection, tendon rupture or lasting nerve injury, are uncommon. Keeping the steroid out of the tendon itself and away from the skin surface is the key to minimising side-effects, and this is one practical situation where seeing the needle on ultrasound helps.

When is surgery considered?

Most people don't need surgery. It's reserved for cases that don't settle with splinting and one or two well-placed injections. The operation is a small procedure to release the first dorsal compartment, opening the tight tunnel so the tendons can glide freely, and it's usually very effective for stubborn cases. Where there's a septum, the surgeon makes sure the EPB subcompartment is fully released too.

Our approach to De Quervain's

My aim is to settle the pain and get your thumb and wrist working normally again, with the least intervention needed.

First, I confirm the diagnosis, checking it really is De Quervain's and not thumb-base arthritis or another cause, using examination and ultrasound. If symptoms are mild, we start with activity modification and a thumb-spica splint, sometimes with simple pain relief. If symptoms persist, an ultrasound-guided corticosteroid injection into the affected compartment, followed by three to four weeks in a thumb-spica splint, gives the best-supported results, and ultrasound lets me confirm the medication reaches the right subcompartment, which matters most when there's a septum. If symptoms recur after a good initial response, a second injection is reasonable; if they don't settle, I'll arrange a surgical opinion for compartment release.

Key message

Frequently asked questions

References